Pan-Cancer (N=930) | HB-Cancer (N=1151) | Pan-disease (N=4409) | HB-disease (N=21002) | Control (N=5895) | Total (N=33387) | p value | |
---|---|---|---|---|---|---|---|
Gender | < 0.0011 | ||||||
   Female | 439 (47.2%) | 430 (37.4%) | 2043 (46.3%) | 11186 (53.3%) | 1681 (28.5%) | 15779 (47.3%) | |
   Male | 491 (52.8%) | 721 (62.6%) | 2366 (53.7%) | 9816 (46.7%) | 4214 (71.5%) | 17608 (52.7%) | |
Ethnicity | < 0.0011 | ||||||
   White | 519 (66.6%) | 549 (53.7%) | 2370 (57.6%) | 10396 (51.5%) | 3280 (57.7%) | 17114 (53.9%) | |
   South Asian | 79 (10.1%) | 230 (22.5%) | 874 (21.2%) | 5207 (25.8%) | 942 (16.6%) | 7332 (23.1%) | |
   Black | 98 (12.6%) | 121 (11.8%) | 408 (9.9%) | 2046 (10.1%) | 806 (14.2%) | 3479 (10.9%) | |
   Far/South-east Asian | 4 (0.5%) | 24 (2.3%) | 19 (0.5%) | 234 (1.2%) | 31 (0.5%) | 312 (1.0%) | |
   Arab/North African | 0 (0.0%) | 0 (0.0%) | 1 (0.0%) | 15 (0.1%) | 5 (0.1%) | 21 (0.1%) | |
   Asian (Other) | 17 (2.2%) | 46 (4.5%) | 178 (4.3%) | 970 (4.8%) | 234 (4.1%) | 1445 (4.5%) | |
   Mixed | 9 (1.2%) | 8 (0.8%) | 49 (1.2%) | 241 (1.2%) | 78 (1.4%) | 385 (1.2%) | |
   Other | 53 (6.8%) | 45 (4.4%) | 217 (5.3%) | 1065 (5.3%) | 306 (5.4%) | 1686 (5.3%) | |
Diagnosis age (years) | < 0.0012 | ||||||
   Mean (SD) | 66.91 (12.72) | 65.24 (13.22) | 52.90 (18.51) | 53.64 (17.67) | 54.77 (17.59) | 54.51 (17.77) | |
   Median | 67.21 | 66.06 | 51.28 | 52.42 | 54.09 | 53.62 | |
   Q1,Q3 | 58.88, 76.07 | 56.79, 75.15 | 38.36, 67.20 | 39.90, 66.40 | 41.02, 68.00 | 40.66, 67.85 | |
Diagnosis age group | < 0.0011 | ||||||
   18-40 | 27 (2.9%) | 54 (4.7%) | 1318 (29.9%) | 5663 (27.0%) | 1470 (24.9%) | 8532 (25.6%) | |
   41-50 | 66 (7.1%) | 100 (8.7%) | 862 (19.6%) | 4149 (19.8%) | 1097 (18.6%) | 6274 (18.8%) | |
   51-60 | 189 (20.3%) | 266 (23.1%) | 773 (17.5%) | 4186 (19.9%) | 1163 (19.7%) | 6577 (19.7%) | |
   61-70 | 290 (31.2%) | 325 (28.2%) | 574 (13.0%) | 3022 (14.4%) | 961 (16.3%) | 5172 (15.5%) | |
   71-80 | 234 (25.2%) | 273 (23.7%) | 519 (11.8%) | 2311 (11.0%) | 733 (12.4%) | 4070 (12.2%) | |
   >80 | 124 (13.3%) | 133 (11.6%) | 363 (8.2%) | 1671 (8.0%) | 471 (8.0%) | 2762 (8.3%) | |
Mortality | < 0.0011 | ||||||
   Deceased | 754 (81.1%) | 795 (69.1%) | 840 (19.1%) | 3634 (17.3%) | 614 (10.4%) | 6637 (19.9%) | |
   Survived | 176 (18.9%) | 356 (30.9%) | 3569 (80.9%) | 17368 (82.7%) | 5281 (89.6%) | 26750 (80.1%) | |
Survival (months) | < 0.0012 | ||||||
   Mean (SD) | 15.88 (24.91) | 22.37 (29.54) | 49.69 (64.39) | 58.03 (77.33) | 57.50 (71.17) | 54.43 (73.08) | |
   Median | 8.05 | 12.47 | 28.93 | 34.87 | 36.57 | 32.20 | |
   Q1,Q3 | 2.58, 18.18 | 3.52, 29.40 | 9.60, 66.17 | 12.50, 73.46 | 14.57, 71.95 | 11.07, 69.57 |
HB-Cancer (N=1151) | HB-disease (N=21002) | Total (N=22153) | p value | |
---|---|---|---|---|
Gender | < 0.0011 | |||
   Female | 430 (37.4%) | 11186 (53.3%) | 11616 (52.4%) | |
   Male | 721 (62.6%) | 9816 (46.7%) | 10537 (47.6%) | |
Ethnicity | 0.0021 | |||
   White | 549 (53.7%) | 10396 (51.5%) | 10945 (51.6%) | |
   South Asian | 230 (22.5%) | 5207 (25.8%) | 5437 (25.6%) | |
   Black | 121 (11.8%) | 2046 (10.1%) | 2167 (10.2%) | |
   Far/South-east Asian | 24 (2.3%) | 234 (1.2%) | 258 (1.2%) | |
   Arab/North African | 0 (0.0%) | 15 (0.1%) | 15 (0.1%) | |
   Asian (Other) | 46 (4.5%) | 970 (4.8%) | 1016 (4.8%) | |
   Mixed | 8 (0.8%) | 241 (1.2%) | 249 (1.2%) | |
   Other | 45 (4.4%) | 1065 (5.3%) | 1110 (5.2%) | |
Diagnosis age (years) | < 0.0012 | |||
   Mean (SD) | 65.24 (13.22) | 53.64 (17.67) | 54.24 (17.65) | |
   Median | 66.06 | 52.42 | 53.19 | |
   Q1,Q3 | 56.79, 75.15 | 39.90, 66.40 | 40.56, 67.22 | |
Diagnosis age group | < 0.0011 | |||
   18-40 | 54 (4.7%) | 5663 (27.0%) | 5717 (25.8%) | |
   41-50 | 100 (8.7%) | 4149 (19.8%) | 4249 (19.2%) | |
   51-60 | 266 (23.1%) | 4186 (19.9%) | 4452 (20.1%) | |
   61-70 | 325 (28.2%) | 3022 (14.4%) | 3347 (15.1%) | |
   71-80 | 273 (23.7%) | 2311 (11.0%) | 2584 (11.7%) | |
   >80 | 133 (11.6%) | 1671 (8.0%) | 1804 (8.1%) | |
Mortality | < 0.0011 | |||
   Deceased | 795 (69.1%) | 3634 (17.3%) | 4429 (20.0%) | |
   Survived | 356 (30.9%) | 17368 (82.7%) | 17724 (80.0%) | |
Survival (months) | < 0.0012 | |||
   Mean (SD) | 22.37 (29.54) | 58.03 (77.33) | 56.17 (76.01) | |
   Median | 12.47 | 34.87 | 33.17 | |
   Q1,Q3 | 3.52, 29.40 | 12.50, 73.46 | 11.53, 71.37 |
HB-Cancer (N=1151) | HB-disease (N=21002) | Total (N=22153) | p value | |
---|---|---|---|---|
Comorbidity | < 0.0011 | |||
   Mean (SD) | 3.46 (2.20) | 2.40 (1.98) | 2.46 (2.01) | |
   Median | 3.00 | 2.00 | 2.00 | |
   Q1,Q3 | 2.00, 5.00 | 1.00, 4.00 | 1.00, 4.00 | |
Diabetes | 427 (37.1%) | 5595 (26.6%) | 6022 (27.2%) | < 0.0012 |
Hypertension | 698 (60.6%) | 10249 (48.8%) | 10947 (49.4%) | < 0.0012 |
Cholesterol | 533 (46.3%) | 8766 (41.7%) | 9299 (42.0%) | 0.0022 |
Asthma | 133 (11.6%) | 3351 (16.0%) | 3484 (15.7%) | < 0.0012 |
COPD | 87 (7.6%) | 1324 (6.3%) | 1411 (6.4%) | 0.0902 |
TB | 19 (1.7%) | 311 (1.5%) | 330 (1.5%) | 0.6432 |
Kidney | 226 (19.6%) | 3705 (17.6%) | 3931 (17.7%) | 0.0852 |
Cardiovascular | 333 (28.9%) | 5631 (26.8%) | 5964 (26.9%) | 0.1142 |
Upper GI | 436 (37.9%) | 7192 (34.2%) | 7628 (34.4%) | 0.0112 |
Lower GI | 129 (11.2%) | 2667 (12.7%) | 2796 (12.6%) | 0.1382 |
F/H: Cancer | 154 (13.4%) | 4309 (20.5%) | 4463 (20.1%) | < 0.0012 |
F/H: Digestive | 41 (3.6%) | 590 (2.8%) | 631 (2.8%) | 0.1352 |
F/H: Diabetes | 234 (20.3%) | 6356 (30.3%) | 6590 (29.7%) | < 0.0012 |
HB-Cancer (N=1151) | HB-disease (N=21002) | Total (N=22153) | p value | |
---|---|---|---|---|
Smoker | < 0.0011 | |||
   Not available | 246 (21.4%) | 2288 (10.9%) | 2534 (11.4%) | |
   Never | 362 (31.5%) | 8547 (40.7%) | 8909 (40.2%) | |
   Past | 322 (28.0%) | 5240 (25.0%) | 5562 (25.1%) | |
   Current | 221 (19.2%) | 4927 (23.5%) | 5148 (23.2%) | |
Drinker | < 0.0011 | |||
   Not available | 407 (35.4%) | 5201 (24.8%) | 5608 (25.3%) | |
   Never | 217 (18.9%) | 4869 (23.2%) | 5086 (23.0%) | |
   Past | 75 (6.5%) | 1023 (4.9%) | 1098 (5.0%) | |
   Current | 452 (39.3%) | 9909 (47.2%) | 10361 (46.8%) | |
Substance user | < 0.0011 | |||
   Not available | 665 (57.8%) | 12167 (57.9%) | 12832 (57.9%) | |
   Never | 189 (16.4%) | 4317 (20.6%) | 4506 (20.3%) | |
   Past | 11 (1.0%) | 98 (0.5%) | 109 (0.5%) | |
   Current | 286 (24.8%) | 4420 (21.0%) | 4706 (21.2%) | |
Obese | < 0.0011 | |||
   Not available | 218 (18.9%) | 2459 (11.7%) | 2677 (12.1%) | |
   Never | 211 (18.3%) | 3815 (18.2%) | 4026 (18.2%) | |
   Past | 478 (41.5%) | 7881 (37.5%) | 8359 (37.7%) | |
   Current | 244 (21.2%) | 6847 (32.6%) | 7091 (32.0%) |
HB-Cancer (N=828) | HB-disease (N=17725) | Total (N=18553) | p value | |
---|---|---|---|---|
Gender | < 0.0011 | |||
   Female | 305 (36.8%) | 9680 (54.6%) | 9985 (53.8%) | |
   Male | 523 (63.2%) | 8045 (45.4%) | 8568 (46.2%) | |
Ethnicity | < 0.0011 | |||
   White | 405 (49.5%) | 8541 (48.4%) | 8946 (48.5%) | |
   South Asian | 210 (25.7%) | 5043 (28.6%) | 5253 (28.4%) | |
   Black | 107 (13.1%) | 1879 (10.6%) | 1986 (10.8%) | |
   Far/South-east Asian | 23 (2.8%) | 205 (1.2%) | 228 (1.2%) | |
   Arab/North African | 0 (0.0%) | 15 (0.1%) | 15 (0.1%) | |
   Asian (Other) | 37 (4.5%) | 879 (5.0%) | 916 (5.0%) | |
   Mixed | 7 (0.9%) | 219 (1.2%) | 226 (1.2%) | |
   Other | 29 (3.5%) | 865 (4.9%) | 894 (4.8%) | |
Diagnosis age (years) | < 0.0012 | |||
   Mean (SD) | 64.49 (13.64) | 52.84 (17.41) | 53.36 (17.43) | |
   Median | 65.05 | 51.53 | 52.19 | |
   Q1,Q3 | 55.28, 74.80 | 39.22, 65.10 | 39.76, 65.84 | |
Diagnosis age group | < 0.0011 | |||
   18-40 | 45 (5.4%) | 4997 (28.2%) | 5042 (27.2%) | |
   41-50 | 77 (9.3%) | 3632 (20.5%) | 3709 (20.0%) | |
   51-60 | 210 (25.4%) | 3528 (19.9%) | 3738 (20.1%) | |
   61-70 | 222 (26.8%) | 2466 (13.9%) | 2688 (14.5%) | |
   71-80 | 176 (21.3%) | 1834 (10.3%) | 2010 (10.8%) | |
   >80 | 98 (11.8%) | 1268 (7.2%) | 1366 (7.4%) | |
Mortality | < 0.0011 | |||
   Deceased | 545 (65.8%) | 2788 (15.7%) | 3333 (18.0%) | |
   Survived | 283 (34.2%) | 14937 (84.3%) | 15220 (82.0%) | |
Survival (months) | < 0.0012 | |||
   Mean (SD) | 24.85 (32.28) | 65.78 (81.22) | 63.96 (80.13) | |
   Median | 14.40 | 42.17 | 40.50 | |
   Q1,Q3 | 4.35, 33.26 | 18.23, 82.13 | 17.10, 79.67 |
HB-Cancer (N=828) | HB-disease (N=17725) | Total (N=18553) | p value | |
---|---|---|---|---|
Comorbidity | < 0.0011 | |||
   Mean (SD) | 4.02 (2.15) | 2.55 (2.02) | 2.61 (2.05) | |
   Median | 4.00 | 2.00 | 2.00 | |
   Q1,Q3 | 2.00, 6.00 | 1.00, 4.00 | 1.00, 4.00 | |
Diabetes | 345 (41.7%) | 4978 (28.1%) | 5323 (28.7%) | < 0.0012 |
Hypertension | 572 (69.1%) | 8933 (50.4%) | 9505 (51.2%) | < 0.0012 |
Cholesterol | 478 (57.7%) | 8132 (45.9%) | 8610 (46.4%) | < 0.0012 |
Asthma | 116 (14.0%) | 3079 (17.4%) | 3195 (17.2%) | 0.0122 |
COPD | 72 (8.7%) | 1077 (6.1%) | 1149 (6.2%) | 0.0022 |
TB | 18 (2.2%) | 306 (1.7%) | 324 (1.7%) | 0.3372 |
Kidney | 186 (22.5%) | 3082 (17.4%) | 3268 (17.6%) | < 0.0012 |
Cardiovascular | 275 (33.2%) | 4676 (26.4%) | 4951 (26.7%) | < 0.0012 |
Upper GI | 410 (49.5%) | 6897 (38.9%) | 7307 (39.4%) | < 0.0012 |
Lower GI | 121 (14.6%) | 2627 (14.8%) | 2748 (14.8%) | 0.8702 |
F/H: Cancer | 154 (18.6%) | 4309 (24.3%) | 4463 (24.1%) | < 0.0012 |
F/H: Digestive | 38 (4.6%) | 559 (3.2%) | 597 (3.2%) | 0.0222 |
F/H: Diabetes | 234 (28.3%) | 6340 (35.8%) | 6574 (35.4%) | < 0.0012 |
HB-Cancer (N=828) | HB-disease (N=17725) | Total (N=18553) | p value | |
---|---|---|---|---|
Smoker | < 0.0011 | |||
   Not available | 6 (0.7%) | 61 (0.3%) | 67 (0.4%) | |
   Never | 331 (40.0%) | 8180 (46.1%) | 8511 (45.9%) | |
   Past | 297 (35.9%) | 5078 (28.6%) | 5375 (29.0%) | |
   Current | 194 (23.4%) | 4406 (24.9%) | 4600 (24.8%) | |
Drinker | < 0.0011 | |||
   Not available | 154 (18.6%) | 2939 (16.6%) | 3093 (16.7%) | |
   Never | 183 (22.1%) | 4566 (25.8%) | 4749 (25.6%) | |
   Past | 74 (8.9%) | 1016 (5.7%) | 1090 (5.9%) | |
   Current | 417 (50.4%) | 9204 (51.9%) | 9621 (51.9%) | |
Substance user | < 0.0011 | |||
   Not available | 444 (53.6%) | 9854 (55.6%) | 10298 (55.5%) | |
   Never | 148 (17.9%) | 3999 (22.6%) | 4147 (22.4%) | |
   Past | 11 (1.3%) | 92 (0.5%) | 103 (0.6%) | |
   Current | 225 (27.2%) | 3780 (21.3%) | 4005 (21.6%) | |
Obese | < 0.0011 | |||
   Not available | 21 (2.5%) | 373 (2.1%) | 394 (2.1%) | |
   Never | 166 (20.0%) | 3524 (19.9%) | 3690 (19.9%) | |
   Past | 428 (51.7%) | 7539 (42.5%) | 7967 (42.9%) | |
   Current | 213 (25.7%) | 6289 (35.5%) | 6502 (35.0%) |